Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.

c-Myc activation in mouse skin increases sebaceous gland growth and affects hair follicle development.

Dermal cells are key in controlling hair growth and could potentially be used in hair loss treatments, but more research is needed to improve hair regeneration methods.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Epidermal stem cells help heal severe skin wounds and have potential for medical treatments.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Mice with too much Claudin-6 have skin barrier problems and abnormal hair growth.

Scalp itching is common and hard to diagnose due to the complex nerve structure of the scalp.

Circadian clock genes are important for hair growth and may affect aging-related hair loss and graying.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Melanocyte stem cells are crucial for skin pigmentation and have potential in disease modeling and regenerative medicine.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Activating Kras in mouse skin causes excess skin and hair loss.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.

Myhre syndrome symptoms worsen over time, with specific genetic variants affecting severity.

Innovative cosmetics could safely change hair color by targeting biological hair pigmentation processes.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Fetal ovaries produce different hormones than adult ovaries, and endocrine-disrupting chemicals may affect this process.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Understanding skin stem cells and their regulation is key to improving skin healing and treating disorders.

Long working hours increase the risk of hair loss in Korean male workers.

Long-term breastfeeding and preterm labor may worsen postpartum hair loss.

The enzymes Tet2 and Tet3 are important for skin cell development and hair growth.